SLA 0.00% $3.34 silk laser australia limited

the alcholics trial, page-56

  1. 225 Posts.
    lightbulb Created with Sketch. 27
    Hi Aksier,

    It surprising that SLA could have announced the results of the trial in October 2006, when the trials were still going in 2007. From yesterdays alcoholics trial, "The Directors of Solagran Limited are pleased to provide a summary of the results of the Ropren® clinical trials conducted at the Skvortsova-Stepanova psychiatric hospital in 2006-07 with serious and critically ill, drug addicted chronic alcoholics".

    C'mon, be a big person, apologise to the thread for misleading them. Denis's own words are beating you up. It's easy and it will allow you to get past your mistake.

    Cheers,

    Bill
 
watchlist Created with Sketch. Add SLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.